견적문의

BETZDORF, LUXEMBOURG & NEUBIBERG, GERMANY--( / )--LuxSpace, a subsidiary of space and technology group OHB SE, and the Universitat der Bundeswehr Munchen (University of German Armed Forces Munich) just signed a contract for the dtec.bw SeRANIS (Seamless Radio Access Network for Internet of Space) small satellite mission. This UniBw M mission provides the world's first publicly accessible multifunctional experimental laboratory in orbit and will use the LuxSpace built Triton-X Heavy platform.

SeRANIS is a small satellite mission with 15 experiments to explore key future technologies in various fields, including future 6G mobile communication systems, laser communication and Internet of Things.

“With the goal to create a multi-functional experimental laboratory on one satellite, the SeRANIS mission is unique and substantially different from traditional “CubeSat” based research approaches. Due to the high complexity of this mission, a reliable and agile platform is needed. The Triton-X Heavy platform prevailed in our call for tenders,” said SeRANIS project leader, Prof. Dr. Andreas Knopp, Professor Space Research Center, Universitat der Bundeswehr Munchen. “The SeRANIS mission has two aims: Paving the way for the Bundeswehr’s access to new capabilities in Low Earth Orbit and offering an orbital lab for the German research community.”

Edgar Milic, CEO of LuxSpace said “LuxSpace is proud and enthusiastic to be part of the SeRANIS mission with our high performance and scalable Triton-X platform for smallsats. The variety of innovative technologies and payloads aboard SeRANIS is an ideal fit for our multi-mission platform developed in Light/Medium/Heavy mass classes for up to 250 kg satellites".

About UniBw and dtec.bw

The Universitat der Bundeswehr Munchen () serves the academic training of military and civilian students. SeRANIS is a research project funded by dtec.bw - Digitalization and Technology Research Center of the Bundeswehr. More on and

About LuxSpace

LuxSpace was established in Luxembourg in 2004 as a subsidiary of OHB SE and is an integrated provider of small satellites and space-based applications and services. The company can look back on seven successfully launched space systems, including the Triton-2/ESAIL satellite launched in September 2020, and has over 16 years of experience in data applications with a particular focus on the maritime sector and Earth observation. More on

View source version on businesswire.com:Korea Newswire distributes your news across every media channels through the industry’s largest press release distribution network

ST. GALLEN, SWITZERLAND 먹튀일번가 & 먹튀일번가 비아그라크기변화 STAMFORD, CONN.--( / )--Regulatory News:

This press 먹튀일번가 발기잘되는법 release features multimedia. 먹튀일번가 수원한국마사회 View the full release here:

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that the European Commission has granted marketing authorization to Kapruvia® (difelikefalin) for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adult hemodialysis patients. 설악동맞고 자하자정 툰타임구 Viformarketing authorization, which approves 먹튀일번가 스피덴정 Kapruvia® for use in all member states of the European Union plus Iceland, Liechtenstein and Norway, follows the U.S. Food and Drug Administration 먹튀일번가 게임동영상 (FDA) approval of KORSUVA™ (difelikefalin) injection in August 2021 for the same indication. Kapruvia® will be the first therapy available in Europe for the treatment of CKD-associated pruritus in hemodialysis patients.

“We are very excited about the European Commission’s approval of Kapruvia®, marking an important milestone on our journey to advance and fundamentally change the treatment paradigm for people living with the severe burden of pruritus associated with chronic kidney disease,” said Dr. Klaus Henning Jensen, Chief Medical 먹튀일번가 메가스포츠야마토릴게임 Officer of Vifor Pharma. “We look forward to bringing this first-in-class therapy 설악동맞고 아프리카tv먹방 to patients in Europe, with launch in first markets expected in the second half of 2022.”

“The European Commission’s approval of Kapruvia® provides a much-needed therapy to hemodialysis patients in Europe who suffer from pruritus,” said Dr. Joana Goncalves, Chief Medical Officer of Cara Therapeutics. “We are excited to bring an innovative drug to physicians to help change the way pruritus is managed. We continue to work with our commercial partner VFMCRP, 먹튀일번가 c컵 to fill a significant unmet medical need among CKD patients with pruritus in both the U.S. and Europe.”

The approval in Europe is based on pivotal clinical data from two phase-III trials, 먹튀일번가 KALM-1 먹튀일번가 and KALM-2, as well as supportive data from an additional 32 clinical studies. These studies showed that treatment with Kapruvia® resulted in clinically meaningful improvements in pruritus severity and in pruritus-related quality of life components and was found to be generally well tolerated in patients with moderate-to-severe CKD-associated pruritus.

보솜이 About먹튀일번가 야마토5 설악동맞고 야마토5 Vifor 먹튀일번가 야마토게임다운로드후 Pharma Group 먹튀일번가 에프엑스시티

Vifor Pharma Group is a global pharmaceuticals company. It aims to become the global leader in iron deficiency and nephrology. The company is a partner of choice for pharmaceuticals and innovative patient-focused solutions across iron, dialysis, nephrology and rare conditions. Vifor Pharma Group strives to help patients around the world 먹튀일번가 동행복권파워볼점검 with severe, chronic and rare diseases lead better, healthier lives. It specializes in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision patient care. Vifor Pharma Group holds a leading position in all its core business activities and includes the companies: Vifor Pharma, Sanifit Therapeutics, and Vifor Fresenius Medical Care Renal Pharma (a joint company 먹튀일번가 파워키노사다리사이트 with Fresenius Medical Care). Vifor Pharma Group is headquartered in Switzerland and listed on the Swiss Stock Exchange (SIX Swiss Exchange, VIFN, ISIN: CH0364749348). For more information, please visit viforpharma.com

For more 먹튀일번가 로또번호 information, 먹튀일번가 로또번호추출기 please visit viforpharma.com. 먹튀일번가 성의학클리닉

PornTube AboutCara 먹튀일번가 성의학 설악동맞고 성의학 Therapeutics

Cara Therapeutics is an early commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus. The Company’s novel KORSUVA™ (difelikefalin) injection is the first and only 먹튀일번가 로토리치 FDA-approved treatment for moderate-to-severe pruritus associated with 먹튀일번가 인터넷로또구매 chronic kidney disease in adults undergoing hemodialysis. The Company is developing an oral formulation of difelikefalin and has initiated Phase 3 programs for the treatment of pruritus in patients with non-dialysis dependent advanced chronic kidney disease and atopic dermatitis. Phase 2 trials of oral difelikefalin are ongoing in primary biliary cholangitis 구르마넷 Caranotalgia paresthetica patients with moderate-to-severe pruritus. For more information, visit and 먹튀일번가 불감증치료 follow the company on Twitter, LinkedIn and Instagram.

About 먹튀일번가 친구로또 알파TV AboutKidney 먹튀일번가 가정폭력 Disease-associated Pruritus

CKD-associated pruritus is 먹튀일번가 창원부부상담 an intractable systemic itch condition that occurs with high frequency and intensity in patients with chronic kidney disease undergoing dialysis. Pruritus has also been reported in patients with stage III-V CKD who are not on dialysis. The majority of dialysis SUPERZOOI CKD-associated(approximately 60 to 70%) report pruritus, with 30 to 40% reporting moderate or severe pruritus.[1,2,3] Data from the ITCH National Registry Study showed that among those with pruritus, approximately 59%[4] experienced symptoms daily or nearly daily for more than a year.

Given its association with CKD/ESRD, most afflicted patients will continue to have symptoms for months or years, with currently employed antipruritic treatments, such as antihistamines and corticosteroids, unable to provide consistent, adequate relief. Moderate-to-severe chronic pruritus has repeatedly been shown to directly decrease 야한동영상모음집 Givenof life, contribute to symptoms that impair quality of life (such as poor sleep quality), and is 먹튀일번가 associated with depression.[4] CKD-associated pruritus is also an independent predictor of mortality and 설악동맞고 명기 the risk for hospitalization among hemodialysis patients.

중국성인영화 Forward-looking먹튀일번가 딜도 Statements

Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation 먹튀일번가 로또판매점모집 Reform Act of 1995. Examples of these forward-looking statements include statements concerning the potential timeline for the launch of difelikefalin solution for injection 설악동맞고 단백질인형 in Europe and the potential of difelikefalin solution for injection to be a therapeutic option for CKD-aP in dialysis dependent patients. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Risks are described more fully in Cara‘s filings with the Securities and Exchange Commission, including the “Risk Factors” section of Cara’s Annual Report on Form 10-K for the year ended 31 December 2021 and its other documents subsequently filed with or furnished to the Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they 먹튀일번가 로또1등비결 were made. Except to the extent required 먹튀일번가 섹시팝 by law, Cara undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the SEXE Statementson which they were made.

References: 먹튀일번가 번호추첨기

[1] Pisoni 먹튀일번가 섹시모델 RL, et al. Pruritus 설악동맞고 로또1등당첨 in haemodialysis patients: international results from the Dialysis Outcomes 먹튀일번가 여고생 and Practice Patterns Study. 심심해 [1]Dial Transplant. 2006; 21:3495-3505.

[2] Ramakrishnan K, 먹튀일번가 애널 et al. Clinical characteristics and outcomes of end-stage renal disease patients with self-reported pruritus symptoms. International Journal of Nephrology and Renovascular Disease. 2014; 7: 1-12.

[3] 먹튀일번가 Sukul et al. Self-reported Pruritus and Clinical, 먹튀일번가 안마 Dialysis-Related, 먹튀일번가 and Patient-Reported Outcomes in Hemodialysis Patients. Kidney Med. 2020 심심해 [3]21;3(1):42-53.

[4] 먹튀일번가 로또대박 Mathur VS, et al. 심심해 [4]먹튀일번가 로또당첨번호조합 longitudinal study of Uremic Pruritus 설악동맞고 무료로또당첨번호 in hemodialysis patients. Clin J Am Soc Nephrol. 2010; 먹튀일번가 5(8):1410-1419.

View 설악동맞고 야하니 source 먹튀일번가 version on businesswire.com:Korea Newswire distributes your news across every 먹튀일번가 로또역사 media channels through the industry’s largest 유리의방 Viewrelease distribution network